Latest Breaking News On - Newscope capital corporation - Page 1 : comparemela.com
Revive Therapeutics Ltd advancing repurposed gout drug to fight coronavirus and is pushing into psychedelic medicine
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Revive Therapeutics Ltd advancing repurposed gout drug to fight coronavirus and is pushing into psychedelic medicine
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Advancing clinical development of gout drug Bucillamine for infectious diseases, including COVID-19
Developing novel psilocybin and cannabidiol therapeutics for central nervous system and inflammatory disorders
Revive Therapeutics Ltd (CSE:RVV) (OTCMKTS:RVVTF) is a life sciences company focused on the research and development of drugs for infectious diseases as well as central nervous system and inflammatory disorders.
Its cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. The company has been granted orphan drug status designation by the US Food and Drug Administration (FDA) for the use of CBD to treat auto-immune hepatitis and FDA orphan drug status designation for the use of CBD to treat ischemia and reperfusion injury from organ transplantations.
Share this article
Share this article
PALM BEACH, Fla., April 14, 2021 /PRNewswire/ The psychedelics industry may appear to have suddenly emerged as one of the hottest corners of the stock market, but researchers have been working for decades to show the efficacy of these treatments and regulators are just starting to appreciate the possibilities. Investors could see strong growth in the industry as companies commercialize breakthrough therapeutics while patients could finally have access to life-changing treatments for a range of mental health conditions that have no effective treatment options today. A recent article by CFN Media Group focused on the newly born psychedelics industry in terms of both its revenue potential and the valuations that investors are assigning to companies in the space. Another article said: The market for psychedelic drugs is projected to grow from just over $2 billion last year to about $6.9 billion by 2027, according to Data Bridge Market Resear
Newscope Announces Name Change Newscope Capital Corporation Vancouver, British Columbia, CANADA
TORONTO, April 08, 2021 (GLOBE NEWSWIRE) Newscope Capital Corporation (the “Company”) (CSE: PHRM) (OTCQB: PHRRF) is pleased to announce that it has filed an alteration notice with BC Registry Services changing the name of the Company to PharmaTher Holdings Ltd. The name change was approved by the Company’s shareholders at the special meeting held on April 5, 2021. The Company will be filing the necessary documentation with the CSE in order to commence trading under its new name.
There is no change in the share capital of the Company or its trading symbol, and shareholders are not required to exchange their existing share certificates for new certificates.
vimarsana © 2020. All Rights Reserved.